Skip to main content
PMC home page
Gut logoLink to Gut
. 1990 Aug;31(8):934–937. doi: 10.1136/gut.31.8.934

Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.

U Leonhardt 1, F Seidensticker 1, M Fussek 1, F Stöckmann 1, W Creutzfeldt 1
PMCID: PMC1378627  PMID: 2387520

Abstract

The effect of peritoneal lavage with the addition of camostate to the lavage fluid on the outcome of taurocholate pancreatitis in rats was studied. Camostate is a low molecular weight protease inhibitor which has been developed recently. Peritoneal lavage was performed for 12 hours and camostate was added to the lavage fluid in five concentrations. At 0.1 mg/ml the survival rate increased significantly (11 of 20 v controls 4 of 20, p less than 0.05); the maximal effect was observed at 0.2 mg/ml, and no effect was seen at 0.01 and 0.05 mg/ml. Adverse effects occurred at 0.5 mg/ml. The addition of 0.1 mg/ml camostate significantly reduced the acidosis in arterial blood: mean (SD) pH 7.30 (0.035) v controls 7.23 (0.054) (n = 9, p less than 0.01) and arterial base excess: -15.4 (1.26) mmol/l v controls: -17.4 (2.51) mmol/l (n = 9, p less than 0.05). There was no difference, however, in plasma amylase activity and in the histological degree of specific tissue damage to the pancreas. A combination of intravenous camostate and lavage with the addition of camostate to the lavage fluid yielded a significantly improved survival compared with treatment with intravenous camostate alone (10 out of 16 animals v intravenous camostate alone, two out of 16, p greater than 0.01). We conclude that lavage with camostate significantly improves the prognosis of severe necrotising pancreatitis in rats.

Full text

PDF
935

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ihse I., Evander A., Gustafson I., Holmberg J. T. Influence of peritoneal lavage on objective prognostic signs in acute pancreatitis. Ann Surg. 1986 Aug;204(2):122–127. doi: 10.1097/00000658-198608000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Lankisch P. G., Koop H., Winckler K., Schmidt H. Continuous peritoneal dialysis as treatment of acute experimental pancreatitis in the rat. I. Effect on length and rate of survival. Dig Dis Sci. 1979 Feb;24(2):111–116. doi: 10.1007/BF01324737. [DOI] [PubMed] [Google Scholar]
  3. Lankisch P. G., Pohl U., Göke B., Otto J., Wereszczynska-Siemiatkowska U., Gröne H. J., Rahlf G. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models. Gastroenterology. 1989 Jan;96(1):193–199. doi: 10.1016/0016-5085(89)90780-4. [DOI] [PubMed] [Google Scholar]
  4. Lankisch P. G., Pohl U., Otto J., Rahlf G. When should treatment of acute experimental pancreatitis be started? The early phase of bile-induced acute pancreatitis. Res Exp Med (Berl) 1988;188(2):123–129. doi: 10.1007/BF01852268. [DOI] [PubMed] [Google Scholar]
  5. Mayer A. D., McMahon M. J., Corfield A. P., Cooper M. J., Williamson R. C., Dickson A. P., Shearer M. G., Imrie C. W. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis. N Engl J Med. 1985 Feb 14;312(7):399–404. doi: 10.1056/NEJM198502143120703. [DOI] [PubMed] [Google Scholar]
  6. Niederau C., Crass R. A., Silver G., Ferrell L. D., Grendell J. H. Therapeutic regimens in acute experimental hemorrhagic pancreatitis. Effects of hydration, oxygenation, peritoneal lavage, and a potent protease inhibitor. Gastroenterology. 1988 Dec;95(6):1648–1657. doi: 10.1016/s0016-5085(88)80091-x. [DOI] [PubMed] [Google Scholar]
  7. Rasmussen B. L. Hypothermic peritoneal dialysis in the treatment of acute experimental hemorrhagic pancreatitis. Am J Surg. 1967 Nov;114(5):716–721. doi: 10.1016/0002-9610(67)90135-3. [DOI] [PubMed] [Google Scholar]
  8. Rodgers R. E., Carey L. C. Peritoneal lavage in experimental pancreatitis in dogs. Am J Surg. 1966 Jun;111(6):792–794. doi: 10.1016/0002-9610(66)90174-7. [DOI] [PubMed] [Google Scholar]
  9. Rosato E. F., Chu W. H., Mullen J. L., Rosato F. E. Peritoneal lavage treatment of experimental pancreatitis. J Surg Res. 1972 Feb;12(2):138–140. doi: 10.1016/0022-4804(72)90134-5. [DOI] [PubMed] [Google Scholar]
  10. Steinberg W. M., Schlesselman S. E. Treatment of acute pancreatitis. Comparison of animal and human studies. Gastroenterology. 1987 Dec;93(6):1420–1427. doi: 10.1016/0016-5085(87)90275-7. [DOI] [PubMed] [Google Scholar]
  11. Wereszczyńska-Siemiatkowska U., Nebendahl K., Pohl U., Otto J., Groene H. J., Wilms H., Lankisch P. G. Influence of buprenorphine on acute experimental pancreatitis. Res Exp Med (Berl) 1987;187(3):211–216. doi: 10.1007/BF01852085. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES